Smad1 activators can be seen as a diverse class of chemical compounds that interact with Smad1 or its upstream pathways to encourage its activation. These chemicals have multifarious mechanisms of action, all converging on the activation of Smad1, which is a key mediator in BMP signaling. For instance, chemicals like DMH1 and LDN-193189 directly interact with BMP type I receptors to augment Smad1 activation. Then there are those like SB431542 and SIS3, which act indirectly by modulating the influence of TGF-β signaling on Smad1. By inhibiting the ALK5 receptor or Smad3 respectively, these chemicals allow Smad1 to become the predominant factor in signaling cascades.
Another intriguing class of Smad1 activators is those that act by modifying the cellular environment to favor Smad1 activity. For example, Lithium Chloride inhibits GSK3β, which indirectly facilitates Smad1 activation by stabilizing microtubules. Forskolin, on the other hand, raises cAMP levels, offering a different avenue for the activation of Smad1. In addition, Isobavachalcone and Indirubin work on stabilizing Smad1 by inhibiting its degradation or enhancing its signaling activity. In summary, these chemicals make up a distinctive class of activators that target either Smad1 directly or modulate upstream pathways and environmental factors to facilitate its activation. The result is the effective promotion of Smad1-dependent cellular processes, achieved through a variety of chemical strategies.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | 1062368-24-4 | sc-476297 | 5 mg | $240.00 | ||
Blocks ALK2, ALK3, and ALK6 receptors, leading to selective activation of Smad1 via BMP signaling. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK3β and can indirectly promote Smad1 activation via stabilization of microtubules. | ||||||
Smad3 Inhibitor, SIS3 | 1009104-85-1 | sc-222318 | 1 mg | $257.00 | 36 | |
Selective inhibitor of Smad3, allowing Smad1 to become more prominent in TGF-β/BMP signaling. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Stimulates adenylate cyclase, which indirectly facilitates Smad1 activation through increased cAMP levels. | ||||||
Isobavachalcone | 20784-50-3 | sc-202666 | 1 mg | $213.00 | 1 | |
Inhibits Smurf1, an E3 ligase that targets Smad1 for degradation, thus increasing Smad1 stability. | ||||||
Indirubin | 479-41-4 | sc-201531 sc-201531A | 5 mg 25 mg | $114.00 $525.00 | 4 | |
Inhibits CDK2 and GSK3β, facilitating Smad1 activation by stabilizing the protein and enhancing its signaling activity. | ||||||
Tranilast | 53902-12-8 | sc-200389 sc-200389A sc-200389B sc-200389C | 10 mg 50 mg 1 g 5 g | $31.00 $103.00 $283.00 $978.00 | 2 | |
Blocks TGF-β and enhances BMP signaling, facilitating Smad1 activation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, which can enhance BMP signaling, leading to Smad1 activation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Demethylating agent that can lead to the expression of BMP receptors, facilitating Smad1 activation. | ||||||